Short bowel syndrome (SBS) is a rare gastrointestinal condition caused by small intestine resection, which leads to poor nutrient absorption and may require special diet and nutritional supplements, including parenteral (intravenous) nutrition to prevent malnutrition.
Ferdia has discovered best-in-class peptides which are superior in preclinical models of SBS and suitable for once-weekly administration in patients.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.